Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 312 followers

Latest posts

Last updated about 10 hours ago

ArsenalBio lays off 50% of staff in pivot from early-stage research

about 10 hours ago

One of the top fundraisers of 2024 is halving its workforce about...

Dexcom CEO goes on leave while Insulet taps new CFO

about 15 hours ago

The changes at the diabetes tech companies include Dexcom announcing that outgoing...

VC Aditum launches cardiovascular biotech, offers Mabwell up to $1B for siRNA asset

about 17 hours ago

California VC firm Aditum Bio is at it again, this time partnering...

J&J's IL-23 drug defeats reigning champ Sotyktu in phase 3 psoriasis trial

about 18 hours ago

After being touted as a potential rival to Bristol Myers Squibb’s reigning...

Regeneron reports phase 3 win in ultra-rare disease, bouncing back to spark race to FDA

about 18 hours ago

Regeneron is racing to regulators after reporting a phase 3 win in...

Lilly rounds out oral GLP-1 weight loss data, posts semaglutide-topping results in diabetes

about 19 hours ago

At this year’s meeting of the European Association for the Study of...

Why Sanofi's R&D chief is 'pretty pragmatic' about a 'mixed' year of clinical development

about 19 hours ago

Sanofi’s head of R&D, Houman Ashrafian, Ph.D., spoke to Fierce days before...

Roivant reports phase 3 autoimmune win for ex-Pfizer asset

about 21 hours ago

A phase 3 trial of Priovant Therapeutics’ inflammatory disease prospect brepocitinib has...

Eye disease biotech launches with $100M and sights set on Roche showdown

about 21 hours ago

During his tenure at Genentech, ophthalmologist Jason Ehrlich supported the development of...

Innate to lose 30% of workforce, including CSO, in focus on ‘highest-value assets’

about 22 hours ago

Innate Pharma is set to lose 30% of its employees, including its...

Pharma tells Scotland how to court investment amid UK life sciences turmoil

about 23 hours ago

With drugmakers freezing investment in the U.K., pharma trade group ABPI has...